Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy

被引:962
作者
Gschwind, A
Fischer, OM
Ullrich, A
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
10.1038/nrc1360
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Receptor tyrosine kinases are a subclass of cell-surface growth-factor receptors with an intrinsic, ligand-controlled tyrosine-kinase activity. They regulate diverse functions in normal cells and have a crucial role in oncogenesis. Twenty years ago, the first primary structure of a receptor tyrosine kinase, the epidermal growth factor receptor, was elucidated. The characterization of both the molecular architecture of receptor tyrosine kinases and the main functions of these proteins and their ligands in tumorigenesis opened the door to a new era in molecular oncology and paved the way to the development of the first target-specific cancer therapeutics.
引用
收藏
页码:361 / 370
页数:10
相关论文
共 136 条
[91]   EPIDERMAL-GROWTH-FACTOR-DEPENDENT ACTIVATION OF THE SRC-FAMILY KINASES [J].
OSHEROV, N ;
LEVITZKI, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 225 (03) :1047-1053
[92]   Escape from Cbl-mediated downregulation: A recurrent theme for oncogenic deregulation of receptor tyrosine kinases [J].
Peschard, P ;
Park, M .
CANCER CELL, 2003, 3 (06) :519-523
[93]   An essential role for ectodomain shedding in mammalian development [J].
Peschon, JJ ;
Slack, JL ;
Reddy, P ;
Stocking, KL ;
Sunnarborg, SW ;
Lee, DC ;
Russell, WE ;
Castner, BJ ;
Johnson, RS ;
Fitzner, JN ;
Boyce, RW ;
Nelson, N ;
Kozlosky, CJ ;
Wolfson, MF ;
Rauch, CT ;
Cerretti, DP ;
Paxton, RJ ;
March, CJ ;
Black, RA .
SCIENCE, 1998, 282 (5392) :1281-1284
[94]   EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF [J].
Prenzel, N ;
Zwick, E ;
Daub, H ;
Leserer, M ;
Abraham, R ;
Wallasch, C ;
Ullrich, A .
NATURE, 1999, 402 (6764) :884-888
[95]  
Presta LG, 1997, CANCER RES, V57, P4593
[96]   FETAL LIVER KINASE-1 IS A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR AND IS SELECTIVELY EXPRESSED IN VASCULAR ENDOTHELIUM [J].
QUINN, TP ;
PETERS, KG ;
DEVRIES, C ;
FERRARA, N ;
WILLIAMS, LT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7533-7537
[97]   ANTI-ONCOGENIC ACTIVITY OF SIGNALING-DEFECTIVE EPIDERMAL GROWTH-FACTOR RECEPTOR MUTANTS [J].
REDEMANN, N ;
HOLZMANN, B ;
VONRUDEN, T ;
WAGNER, EF ;
SCHLESSINGER, J ;
ULLRICH, A .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (02) :491-498
[98]   A CHIMERIC RECEPTOR ALLOWS INSULIN TO STIMULATE TYROSINE KINASE-ACTIVITY OF EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
RIEDEL, H ;
DULL, TJ ;
SCHLESSINGER, J ;
ULLRICH, A .
NATURE, 1986, 324 (6092) :68-70
[99]  
Sato J D, 1983, Mol Biol Med, V1, P511
[100]   THE NEU ONCOGENE - AN ERB-B-RELATED GENE ENCODING A 185,000-MR TUMOR-ANTIGEN [J].
SCHECHTER, AL ;
STERN, DF ;
VAIDYANATHAN, L ;
DECKER, SJ ;
DREBIN, JA ;
GREENE, MI ;
WEINBERG, RA .
NATURE, 1984, 312 (5994) :513-516